C. Calandri

1.8k total citations
24 papers, 1.5k citations indexed

About

C. Calandri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, C. Calandri has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in C. Calandri's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Treatment and Pharmacology (7 papers). C. Calandri is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Treatment and Pharmacology (7 papers). C. Calandri collaborates with scholars based in Italy, United States and Germany. C. Calandri's co-authors include Lucio Crinò, Federico Cappuzzo, Stefania Bartolini, Elisa Rossi, Maurizio Tonato, Giovanni Luca Ceresoli, Vanesa Gregorc, Carlo Paties, Elisabetta Magrini and Alessandra Cancellieri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

C. Calandri

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Calandri Italy 15 944 920 387 165 136 24 1.5k
Claudia Lebedinsky United States 15 732 0.8× 693 0.8× 259 0.7× 129 0.8× 252 1.9× 54 1.5k
N. Schleucher Germany 19 802 0.8× 610 0.7× 598 1.5× 161 1.0× 173 1.3× 32 1.6k
Antoine Adenis France 24 698 0.7× 1.1k 1.2× 289 0.7× 92 0.6× 200 1.5× 84 2.0k
Giorgio Bovo Italy 23 498 0.5× 488 0.5× 429 1.1× 207 1.3× 71 0.5× 63 1.5k
José Barrueco United States 17 1.3k 1.4× 1.1k 1.2× 465 1.2× 39 0.2× 204 1.5× 36 2.0k
A. Lecesne France 15 563 0.6× 1.3k 1.4× 227 0.6× 227 1.4× 162 1.2× 39 2.1k
Rafal Wierzbicki Canada 13 1.1k 1.2× 845 0.9× 325 0.8× 32 0.2× 160 1.2× 29 1.6k
Paola Aimone Switzerland 17 549 0.6× 338 0.4× 372 1.0× 235 1.4× 89 0.7× 43 1.1k
Joanne Lager United States 17 439 0.5× 389 0.4× 563 1.5× 296 1.8× 215 1.6× 37 1.2k
Mark Shapiro United States 21 471 0.5× 537 0.6× 157 0.4× 351 2.1× 197 1.4× 49 1.4k

Countries citing papers authored by C. Calandri

Since Specialization
Citations

This map shows the geographic impact of C. Calandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Calandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Calandri more than expected).

Fields of papers citing papers by C. Calandri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Calandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Calandri. The network helps show where C. Calandri may publish in the future.

Co-authorship network of co-authors of C. Calandri

This figure shows the co-authorship network connecting the top 25 collaborators of C. Calandri. A scholar is included among the top collaborators of C. Calandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Calandri. C. Calandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhuli, K, Cristian Micheletti, Paolo Enrico Maltese, et al.. (2023). The Role of Olive Tree Polyphenols In The Prevention of COVID-19: A Scoping Review Part 2.. PubMed. 174(Suppl 2(6)). 149–153. 1 indexed citations
2.
Lelli, G., Benedetta Urbini, Francesco Bonetti, et al.. (2008). The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice. Journal of Chemotherapy. 20(3). 374–379. 4 indexed citations
3.
Cappuzzo, Federico, Giovanna Finocchiaro, Elisa Rossi, et al.. (2007). EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients. Annals of Oncology. 19(4). 717–723. 215 indexed citations
4.
Cappuzzo, Federico, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.. (2004). Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 96(15). 1133–1141. 311 indexed citations
5.
Cappuzzo, Federico, Stefania Bartolini, Giovanni Luca Ceresoli, et al.. (2004). Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC). British Journal of Cancer. 90(1). 82–86. 56 indexed citations
6.
Cappuzzo, Federico, Vanesa Gregorc, Elisa Rossi, et al.. (2003). Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology. 21(14). 2658–2663. 175 indexed citations
7.
Cappuzzo, Federico, Andrea Ardizzoni, Héctor Soto Parrà, et al.. (2003). Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). Lung Cancer. 41(2). 227–231. 92 indexed citations
8.
Crinò, Lucio & C. Calandri. (2002). Gemzar platinum combinations: phase III trials in non-small cell lung cancer. Lung Cancer. 38. 9–12. 12 indexed citations
9.
Marucci, Gianluca, et al.. (2001). Gemcitabine-associated CD8+ CD30+ pseudolymphoma.. British Journal of Dermatology. 145(4). 650–652. 14 indexed citations
10.
Crinò, Lucio, Anna Maria Mosconi, C. Calandri, et al.. (2001). Gemcitabine in Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 24(3). 296–298. 15 indexed citations
11.
Marucci, Gianluca, et al.. (2001). Gemcitabine-associated CD8+ CD30+ pseudolymphoma.. British Journal of Dermatology. 145(4). 650–652. 7 indexed citations
12.
Rinaldi, Monica, Lucio Crinò, Giorgio V. Scagliotti, et al.. (2000). A three-week schedule of gemcitabine–cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomized trial. Annals of Oncology. 11(10). 1295–1300. 46 indexed citations
13.
Rand, Jacob H., Xiao-Xuan Wu, Harry A.M. Andree, et al.. (1998). Antiphospholipid Antibodies Accelerate Plasma Coagulation by Inhibiting Annexin-V Binding to Phospholipids: A “Lupus Procoagulant” Phenomenon. Blood. 92(5). 1652–1660. 140 indexed citations
14.
Rand, Jacob H., Xiao-Xuan Wu, Harry A.M. Andree, et al.. (1998). Antiphospholipid Antibodies Accelerate Plasma Coagulation by Inhibiting Annexin-V Binding to Phospholipids: A “Lupus Procoagulant” Phenomenon. Blood. 92(5). 1652–1660. 5 indexed citations
15.
Mosconi, Anna Maria, Giorgio V. Scagliotti, Giovanni Selvaggi, et al.. (1998). Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.. PubMed. 25(4 Suppl 9). 23–6. 17 indexed citations
16.
Crinò, Lucio, et al.. (1997). Gemcitabine in advanced pancreatic cancer: A phase II trial. European Journal of Cancer. 33. S280–S280. 6 indexed citations
17.
Crinò, Lucio, Giorgio V. Scagliotti, Filippo de Marinis, et al.. (1997). 74 Salvage therapy with gemcitabine (GEM) in pretreated, advanced non-small cell lung cancer (NSCLC). Lung Cancer. 18. 22–22. 16 indexed citations
18.
Krikun, Graciela, Charles J. Lockwood, Xiaofeng Wu, et al.. (1994). The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation. Placenta. 15(6). 601–612. 118 indexed citations
19.
Niesvizky, Rubén, et al.. (1994). von Willebrand factor binding to collagen in patients with end-stage renal disease.. PubMed. 123(1). 137–42. 7 indexed citations
20.
Saggi, Subodh J., et al.. (1990). Renal Failure Due to Leukaemic Infiltration in Chronic Lymphocytic Leukaemia. Nephrology Dialysis Transplantation. 5(12). 1051–1052. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Lebedinsky Breakdown of academic impact, for papers by N. Schleucher Breakdown of academic impact, for papers by Antoine Adenis Breakdown of academic impact, for papers by Giorgio Bovo Breakdown of academic impact, for papers by José Barrueco Breakdown of academic impact, for papers by A. Lecesne Breakdown of academic impact, for papers by Rafal Wierzbicki Breakdown of academic impact, for papers by Paola Aimone Breakdown of academic impact, for papers by Joanne Lager Breakdown of academic impact, for papers by Mark Shapiro
Rankless by CCL
2026